Robert Månsson Welinder

Head of Unit: National Genomics Infrastructure, KTH Royal Institute of Technology

Key publications

1. Aging is associated with functional and molecular changes in distinct hematopoietic stem cell subsets
Su T-Y, Hauenstein J, Somuncular E, Dumral Ö, Leonard E, Gustafsson C, Tzortzis E, Forlani A, Johansson A-S, Qian H, Månsson R, Luc S
Nature Communications, in press

2. T-RHEX-RNAseq – A tagmentation-based, rRNA blocked, random hexamer primed RNAseq method for generating stranded RNAseq libraries directly from very low numbers of lysed cells.
Gustafsson C, Hauenstein J, Frengen N, Krstic A, Luc S, Månsson R.
BMC Genomics. 2023 Apr 17;24(1):205. PMID: 37069502

3. Linked-read whole-genome sequencing resolves common and private structural variants in multiple myeloma.
Peña-Pérez L, Frengen N, Hauenstein J, Gran C, Gustafsson C, Eisfeldt J, Kierczak M, Taborsak-Lines F, Olsen RA, Wallblom A, Krstic A, Ewels P, Lindstrand A, Månsson R.
Blood Adv. 2022 Sep 13;6(17):5009-5023. PMID: 35675515

4. FOXO dictates initiation of B cell development and myeloid restriction in common lymphoid progenitors
Peña-Pérez L*, Kharazi S*, Frengen N, Krstic A, Bouderlique T, Hauenstein J, He M, Somuncular E, Li Wang X, Dahlberg C, Gustafsson C, Johansson A-S, Walfridsson J, Kadri N, Woll P, Kierczak M, Qian H, Westerberg L, Luc S, Månsson R
Front Immunol. 2022 May 4;13:880668. PMID: 35603175.

5. High-Throughput ChIPmentation: freely scalable, single day ChIPseq data generation from very low cell-numbers
Gustafsson C, De Paepe A, Schmidl C and Månsson R
BMC Genomics. 2019 Jan 18;20(1):59. PMID: 30658577

6. Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma.
Jin Y*, Chen K*, De Paepe A*, Hellqvist E, Krstic AD, Metang L, Gustafsson C, Davis RE, Levy YM, Surapaneni R, Wallblom A, Nahi H, Mansson R#, Lin YC#.
Blood. 2018 May 10;131(19):2138-2150. PMID: 29519805

# Senior authors contributed equally to this work. * First authors contributed equally.

Within the frame of my research team at the National Genomics Infrastructure (NGI), our overarching aim is to develop and establish sequencing based technologies that can serve the wider Swedish research community.

Our research interests spans the omics field and range from establishing automated high-throughput epigenetic assays and flexible low input RNAsequencing platforms to developing whole-genome sequencing approaches to tackle analysis of FACS sorted single cells as well as complex tumor genomes. We are also interested in the base sequencing technology platforms and utilizing these to provide novel capabilities and spatial multi-omics assays.

Last updated: 2025-01-09

Content Responsible: Hampus Persson(hampus.persson@scilifelab.uu.se)